INNOVATION REVIEW: Closed, Open, Collaborative, Disruptive, Inclusive, Nested… and soon Reverse How about the Metrics: Dream and Reality
暂无分享,去创建一个
[1] M. Feldman,et al. Entpreprenerial Universities and Technology Transfer: A Conceptual Framework for Understanding Knowledge-Based Economic Development , 2006 .
[2] A. Salter,et al. Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms , 2006 .
[3] Clayton M. Christensen,et al. Disruptive Technologies: Catching the Wave , 1995 .
[4] Eric Mankin,et al. Measuring innovation performance , 2007, Innovation for Sustainable Development Review – Belarus.
[5] Heidi Ledford. Universities struggle to make patents pay , 2013, Nature.
[6] Louis J. Picker,et al. HIV-1 Vaccines and Adaptive Trial Designs , 2011, Science Translational Medicine.
[7] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[8] Vinit Nijhawan,et al. MORE THAN MONEY: THE EXPONENTIAL IMPACT OF ACADEMIC TECHNOLOGY TRANSFER. , 2014, Technology and innovation.
[9] Erwin Danneels. Disruptive Technology Reconsidered: A Critique and Research Agenda , 2004 .
[10] E. Thiel,et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.
[11] J. West,et al. Open innovation : researching a new paradigm , 2008 .
[12] A. Bouchie,et al. Nature Biotechnology's academic spinouts of 2013 , 2014, Nature Biotechnology.
[13] I. Cockburn,et al. Public-Private Interaction and the Productivity of Pharmaceutical Research , 1997 .
[14] Damien Lapray,et al. "Bigger Data" Visualization to Visual Analytics: a path to Innovation. "Happening, definitely! Misleading, possibly?" A review of some examples applicable to IP Discovery , 2014 .
[15] H. Chesbrough,et al. A better way to innovate. , 2003, Harvard business review.
[16] Damien Lapray,et al. A Review assessing the "used in the art" Intellectual Property Search Methods and the Innovation Impact therewith , 2014 .
[17] K I Kaitin,et al. Deconstructing the Drug Development Process: The New Face of Innovation , 2010, Clinical pharmacology and therapeutics.
[18] F. Narin,et al. Direct validation of citation counts as indicators of industrially important patents , 1991 .
[19] B. Munos. Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.
[20] Diana P. Hoyt. The Innovation Master Plan: The CEO's Guide to Innovation, Volume 2 , 2012 .
[21] A. Trkola,et al. HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] Graham Warwick,et al. Going for growth , 2010, Nature.
[23] H. Etzkowitz. Innovation in Innovation: The Triple Helix of University-Industry-Government Relations , 2002 .
[24] Georges Haour,et al. From Science to Business: How Firms Create Value by Partnering with Universities , 2010 .
[25] G. Kleter,et al. Genetically modified animals from life-science, socio-economic and ethical perspectives: examining issues in an EU policy context. , 2013, New biotechnology.
[26] Clayton M. Christensen,et al. The innovator's DNA. , 2009, Harvard business review.
[27] David Saltmarsh,et al. Seeking to teach equitably: Australian teacher education in a globalised world , 2013 .
[28] Milton Narváez. The Global Innovation Index 2012 , 2013 .
[29] B. Kirkpatrick,et al. Stem Cell Research and Therapy: The Position of the National Society of Genetic Counselors , 2013, Journal of Genetic Counseling.
[30] J. Manyika,et al. Disruptive technologies: Advances that will transform life, business, and the global economy , 2013 .
[31] S. Anthony,et al. Mapping your innovation strategy. , 2006, Harvard business review.